Pillar 1
Innovators re-imagining how we heal, move, and stay strong – advancing therapies and technologies that support lifelong wellness.
The FITCI companies working in Life Science and Longevity:
AAVion LLC – Specializing in innovative AAV gene therapy, AAVion offers tailored expertise in gene delivery, expression, and comprehensive support from experimental design through final analysis, guiding you toward a successful Investigational New Drug (IND) application.
Advanced In Vitro – Innovation for Human-relevant testing using new approach methodologies (NAMs). NAMs are an integration of biological test systems and assay methodologies to address unmet needs in refining product development and evaluation. State-of-the-art technologies are combined with the current understanding of science to evaluate product efficacies and potential adverse events associated with exposure. AIV specializes in developing and providing human tissue-based test systems referred to as precision-cut slices to researchers. Learn about research conducted using novel approaches that advanced the field of NAM.
Alithea Genomics is a next‑generation transcriptomics company headquartered in Switzerland with U.S. operations in Frederick, MD. Founded in 2020, the company has built a high‑throughput RNA‑seq platform that dramatically lowers cost and time for large‑scale gene‑expression studies, using technologies such as BRB‑seq and MERCURIUS DRUG‑seq. They empower biotech, pharma and academic labs to run hundreds to thousands of samples in one tube, skip tedious prep, and get to publication‑quality data faster. The result: faster biomarker discovery, better screening, and more scalable biology for the next wave of drug development.
AmeboGenesis is revolutionizing the safety‑testing market by producing bio‑identical amebocytes in the lab to replace the annual harvesting of ~800,000 horseshoe crabs for endotoxin testing. With our sustainable, scalable cell‑culture technology we offer the pharma and medical‑device industry a more reliable, ethical and cost‑effective alternative—enabling safer drugs and devices while preserving a vulnerable species.
ArgentysBio‘s proprietary platform enables rapid discovery and optimization of novel antibody sequences using AI/ML-driven epitope mapping, CDR design, in silico screening, and engineering. Clients submit an antigen sequence or structure, and our integrated pipeline delivers fully characterized, manufacturable lead candidates, ready for further development.
BioEvanesce is developing an advanced resorbable biomaterial to prevent the formation of post-surgical adhesions, targeting over 80% efficacy. Over 90% of people who undergo abdominal and gynecological surgeries, including caesarean sections, develop peritoneal adhesions, which are irreversible bands of scar tissue. A third of these patients are readmitted to the hospital at least twice due to adhesion-relation complications, such as life-threatening bowel obstructions, chronic pain, or infertility. BioEvanesce’s sprayable hydrogel will demonstrably reduce overall healthcare costs and improve surgical outcomes and patients’ quality of life.
BioSolution Designs is developing complex DNA-encoded technologies for multigenic biotechnology applications through OspreyBio, the first gene-and-cell therapy-centric biotools company, and Multigenix, their multigenic delivery systems company.
CarrTech Corp. is a medical device company that has patented, prototyped, and built FROG: a better filter needle. For healthcare professionals a complicated process of filtering certain medications involves multiple needles and multiple steps. It is fraught with dangers including needle stick injuries, sepsis, and wasted time. CarrTech Corp’s FROG is a FDA-approved one needle, one step filter that is cheaper, easier, safer, and greener, saving hospitals time and money
Catoctin Bio brings 15 years of expertise in RNA research in industry, academic, and government settings. From full-scope project leadership to niche support, Catoctin Bio provides custom-tailored client collaborations including development + consultation, experiment design + execution, data, reports + analysis, advanced visuals + models, actionable recommendations, and education + resources.
Cornerstone Genomics is transforming how we interpret genetic variation by combining human genomics with deep evolutionary insights. Through its CodeXome platform, the company uses cross-species data—especially from primates—to reclassify variants of uncertain significance and accelerate discoveries in diagnostics and drug development. Based in Frederick, Maryland, Cornerstone helps researchers and clinicians move from genomic data to actionable answers, faster and with greater confidence.
Cytomos, headquartered in Scotland, is a purpose and impact driven organisation that is successfully repurposing microelectronics to enable the cost-effective use of biotechnologies and allow economies of scale. AuraCyt™ was developed by an in-house team, and we are continuing to work on a number of proof-of-concept studies in partnership with exciting large biotechs and pharma companies who see the value in this novel technology.
ExcelCoat Technologies delivers advanced surface‑coating and material‑enhancement solutions from its base in Frederick, MD. Whether it’s improving durability, performance or aesthetics across industrial, medical, or specialty applications, they partner with innovators to apply next‑gen coatings that unlock new value in their products. Think smarter surfaces, longer life, better performance—all engineered to match exact needs.
EXIT Bio is a Frederick-based biotech company developing advanced 3D tissue models that accelerate therapeutic discovery and improve clinical relevance. Using patient-derived cells and human extracellular matrix (ECM), their novel platform recreates realistic tumor microenvironments for rapid, high-content drug screening. These all-human models offer a cost-effective solution to generate more predictive data than traditional systems, helping researchers and industry partners bridge the gap between preclinical testing and patient outcomes.
GenoVector is currently developing a targeted plasmid DNA vector delivery to any specific cell types in vivo.
Established in 2009, Himalaya Nutravedics are the Best Nutraceutical and Ayurvedic formulation Company in Hyderabad that involves third-party contract manufacturing and loan licenses. We provide high-quality products that are manufactured as per FSSAI (Food Safety and Standards Authority of India) and AYUSH license under the proper guidance of skilled professionals and processed with the optimum grade compounds. Till date, we have an established domestic market of 100+ products.
Lactea Therapeutics‘ patent-pending technology and products harness the power of endemic proteins, which have evolved over millions of years to protect us more broadly than we can today.
The early mammalian innate immune factors were nature’s answer to protect our children before they had an active immune system of their own. Current pharmaceutical technologies target the pathogens, and the diseases they cause but do little to protect our cells directly.
At Lyme Research & Healing Center, we specialize in uncovering and treating persistent Lyme disease and co‑infections through advanced scanning, tailored protocols and a patient‑centered healing model. Our ‘GoodbyeLyme’ methodology brings clarity to complex symptoms, targets root causes and supports lasting recovery — so people regain their health, their life and their vitality.
Medical Biotechnology Engineering specializes in custom antibodies and protein services for drug discovery and life science research. Their expertise in recombinant antibody and protein engineering drives innovative solutions to expand treatment options and deliver optimal biologics to patients.
Mesa Science Associates, Inc. provides a comprehensive array of pharmaceutical development solutions to the research community including the Federal Government. From product development planning to NDA or BLA submission, their flexible service model leverages a network of highly skilled research and research support professionals from across the US. Their network includes professionals from all aspects of pharmaceutical development activities including: Formulation Services, Pre-clinical Services, Clinical Services, Regulatory Services , and Manufacturing Services. A Veteran Owned Small Business
Nanocrine is pioneering the commercial availability of nanoplasmonic biosensors for everyday use in leading cell biology laboratories. We design our biosensors as single use biochips that work with standard live cell microscopes and require no new instrumentation – simply open the packages, gather data, and achieve breakthrough results at affordable prices. Their plasmonic biosensors are being developed to image the protein secretions of live cells in real time. Our goal is to empower researchers with the capacity to obtain advanced understanding of their cells’ behaviors, enhancing the precision and reproducibility of their live cell imaging experiments.
NEOPATHOLOGY CORP. is developing a new generation of highly accurate and rapidly reported precision tissue diagnostics and assays which beyond making more accurate diagnosis, can stratify specific disease patients for better treatment and clinical outcomes.
OncoGone, Inc. is developing a safer and more effective chemotherapy hydrogel containing two chemo drugs. The product is to be injected to a cancer site to kill tumor cells, a locally administered chemotherapy capable of simultaneously delivering multiple drugs. This allows reduced toxicity, simultaneous administration of multiple drugs, higher therapeutic efficacy, and less frequent drug administration.
Pace® Life Sciences-GXP Consulting Services helps pharmaceutical and biotech companies achieve and maintain GxP compliance from early development through commercialization. Our GxP Consulting Division provides expert guidance to ensure quality and regulatory readiness across the product lifecycle from design and implementation of phase appropriate quality systems to supplier and internal audits to ensuring data integrity and compliance in testing. As part of the broader Pace Life Sciences organization, our consulting team collaborates closely with our extensive CRDMO network, as well as with colleagues in Regulatory Consulting, Technical Field Services, and Scientific Outsourcing , to deliver end-to-end support across the drug development life cycle.
Potomac Affinity Proteins is currently developing proteases for use in life science research, in medical diagnostics, in biodefense, and in therapeutics. Their approach to protease engineering is to create simple components that can be assembled into more complex, multi-component enzymatic machines. Simple components, once fully characterized, can be combined to form switches, signal amplifiers, and transducers.
PRONAV Clinical is a boutique early‑phase clinical trial supply partner built for biotech innovators. From GMP lab selection and product certification to ultra‑cold‑chain packaging (‑80 °C) and global distribution, their end‑to‑end service ensures investigational products arrive on time and compliant — so trials stay on track and patients don’t have to wait. Driven by precision, speed and transparent communication, PRONAV is the trusted supply‑chain companion for companies advancing tomorrow’s therapies.
Theradaptive is dedicated to developing innovative therapeutics through advanced protein engineering, aiming to improve the delivery and efficacy of treatments for patients suffering from debilitating conditions related to tissue damage. Their mission is to create safer and more effective therapeutics that address unmet medical needs, particularly in the fields of vascular, soft tissue, and orthopedic repair.
TeloHealthDx LLC is a biotechnology company specializing in telomere profiling technology. Our mission is to enhance human healthspan through the development of innovative and affordable telomere profiling tests, aimed at health assessment, diagnostics, and research. Telomere profiling tests comprehensively assess the dynamics of human telomere system. Patients with suspected telomere-related health conditions—such as premature aging, idiopathic pulmonary fibrosis, liver cirrhosis, unexplained leucopenia, and bone marrow failure—can benefit from the telomere profiling test, which aids in diagnosis, early detection, and monitoring of treatment responses.
Up Therapeutics is a preclinical stage biotech company aiming to improve the quality and quantity of cancer patient’s life by leveraging its proprietary novel class of small molecule Rpn13 inhibitors.
VERALOX Therapeutics is developing new therapies for life-threatening immuno-inflammatory diseases. Veralox is a clinical stage company developing drug products targeting the 12-Lipoxygenase and cGAS pathways.
